Skip to main content
. 2020 Dec 15;7(1):e644. doi: 10.1097/TXD.0000000000001080

FIGURE 1.

FIGURE 1.

Infectious complications after treatment for cAMR vs control. AMR, antibody-mediated rejection; BKV, BK virus; cAMR, chronic active antibody-mediated rejection; CMV, cytomegalovirus; UTI, urinary tract infection.